Loading...
The Cannabist Company Holdings Inc.
CBST.NE•NEO
HealthcareDrug Manufacturers - Specialty & Generic
CA$0.07
CA$0.01(15.38%)
The Cannabist Company Holdings Inc. (CBST.NE) Financial Performance & Statements
Review The Cannabist Company Holdings Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-10.29%
↓ 10.29%
Operating Income Growth
78.84%
↑ 78.84%
Net Income Growth
39.74%
↑ 39.74%
Operating Cash Flow Growth
-412.93%
↓ 412.93%
Operating Margin
-4.65%
↓ 4.65%
Gross Margin
35.03%
↑ 35.03%
Net Profit Margin
-24.32%
↓ 24.32%
ROE
1010.60%
↑ 1010.60%
ROIC
-4.68%
↓ 4.68%
The Cannabist Company Holdings Inc. (CBST.NE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for The Cannabist Company Holdings Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $96.14M | $114.78M | $125.16M | $122.06M |
| Cost of Revenue | $62.24M | $70.97M | $83.81M | $86.09M |
| Gross Profit | $33.90M | $43.81M | $41.36M | $35.98M |
| Gross Profit Ratio | $0.35 | $0.38 | $0.33 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $40.59M | $43.30M | $33.35M | $46.67M |
| Operating Expenses | $47.81M | $49.44M | $33.35M | $46.67M |
| Total Costs & Expenses | $110.05M | $120.41M | $117.18M | $132.75M |
| Interest Income | $2.17M | $338000.00 | $0.00 | $138000.00 |
| Interest Expense | $12.44M | $9.95M | $10.61M | $9.47M |
| Depreciation & Amortization | $9.66M | $11.77M | $13.58M | $13.90M |
| EBITDA | -$31.35M | $41.80M | $21.59M | -$1.75M |
| EBITDA Ratio | -$0.33 | $0.36 | $0.17 | -$0.01 |
| Operating Income | -$13.92M | -$5.63M | $8.006M | -$10.69M |
| Operating Income Ratio | -$0.14 | -$0.05 | $0.06 | -$0.09 |
| Other Income/Expenses (Net) | -$38.28M | $25.70M | -$12.007M | -$14.96M |
| Income Before Tax | -$52.19M | $20.07M | -$4.001M | -$25.59M |
| Income Before Tax Ratio | -$0.54 | $0.17 | -$0.03 | -$0.21 |
| Income Tax Expense | $2.96M | $21.84M | $9.64M | $8.83M |
| Net Income | -$54.61M | -$1.86M | -$14.34M | -$34.92M |
| Net Income Ratio | -$0.57 | -$0.02 | -$0.11 | -$0.29 |
| EPS | -$0.12 | -$0.004 | -$0.03 | -$0.08 |
| Diluted EPS | -$0.12 | -$0.004 | -$0.03 | -$0.08 |
| Weighted Avg Shares Outstanding | $462.50M | $470.55M | $460.65M | $445.63M |
| Weighted Avg Shares Outstanding (Diluted) | $462.50M | $470.55M | $460.65M | $445.63M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan